ABK Biomedical

Halifax, Canada · Founded 2012 · $104.0M raised

Headquarters
Halifax
Employees
11–50
Founded
2012
Business Model
B2B
Total Funding
$104.0M
Last Round
$35.0M Series DOct 2025
Rounds
5

About

ABK Biomedical is a Halifax, Nova Scotia-based clinical-stage medical device company, spun out of Dalhousie University in 2012, that designs imageable embolic microsphere products for interventional oncology. Its Eye90 microspheres are used for Y90 radioembolization of liver tumors with in-procedure visualization, while its Easi-Vue embolic microspheres have FDA 510(k) clearance for treating arteriovenous malformations and hypervascular tumors. The company operates GMP manufacturing facilities in Halifax and is running the pivotal ROUTE90 study of Eye90 in unresectable hepatocellular carcinoma.

Summary

ABK Biomedical is a Healthcare company based in Halifax, Canada, founded in 2012. It has raised $104.0M in total across 5 rounds, most recently a $35.0M Series D round in Oct 2025. Investors include F-Prime Capital, J.P. Morgan Life Sciences Private Capital and Sante Ventures.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DOct 2025
$35.0M

Sign up to see all 5 rounds

Seed through Series D — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ABK Biomedical on Indexed.vc
<a href="https://indexed.vc/companies/abk-biomedical"><img src="https://indexed.vc/api/badge/company/abk-biomedical" alt="ABK Biomedical on Indexed.vc" width="260" height="76" /></a>